Article info
PDFCommentary
Tragic choices
- Correspondence to Professor Matthew C Kiernan, Neuroscience Research Australia and University of New South Wales, Barker Street, Randwick, Sydney, NSW 2031, Australia; M.kiernan{at}unsw.edu.au
Citation
Tragic choices
Publication history
- Received July 23, 2013
- Accepted July 31, 2013
- First published August 14, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan
- Amyotrophic lateral sclerosis and motor neuron syndromes in Asia
- Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
- Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
- Clinical trials in the ALS syndrome: it is time for change
- Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
- Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
- Stem cell renegades or pioneers?
- Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
- Composite endpoint for ALS clinical trials based on patient preference: Patient-Ranked Order of Function (PROOF)